The American Society of Clinical Oncology’s (ASCO’s) Advancing Innovation in Residency Education (AIRE) pilot entitled “Combined Oncology and Hospice and Palliative Medicine (HPM) Training” will allow fellows to complete hematology and medical oncology (HEM-ONC) and hospice and palliative medicine (HPM) education in three instead of four years. The pilot will reduce total training by eliminating elective/research time and “double-counting” some ONC and HPM clinical experiences. Approved HEM-ONC and HPM programs that have fellows participating in the pilot will identify them in ADS as follows:
- Fellows participating in the pilot must be listed as “Active Part Time” on both the HEM-ONC and HPM program’s fellow roster in ADS.
- In addition to the “Active Part Time” status, the fellow must also be identified as participating in the AIRE pilot through both program’s AIRE tab. Please follow the instructions for managing fellow AIRE participation found here:
- Identifying pilot fellows as “Active Part Time” and participating in the AIRE pilot will allow that fellow to participate in both the HEM-ONC and HPM program’s ACGME Fellow Survey. Both programs will also have to complete Milestones for the fellow as well.